Streptokinase

CHEMBL2108147 Phase 4 Approuvé Enzyme

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

Derived from streptococcal bacteria, this clot-dissolving enzyme breaks down fibrin, the protein mesh that holds blood clots together, and is used to treat heart attacks, pulmonary embolism, and acute stroke when administered quickly. Because it can cause significant bleeding and allergic reactions, it has been largely superseded by more targeted clot-busting drugs in many settings.

Aires thérapeutiques

Cardiovascular Disease Systemic Lupus Erythematosus Stroke Deep Vein Thrombosis / Pulmonary Embolism

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Derived from streptococcal bacteria, this clot-dissolving enzyme breaks down fibrin, the protein mesh that holds blood clots together, and is used to treat heart attacks, pulmonary embolism, and acute stroke when administered quickly. Because it can cause significant bleeding and allergic reactions, it has been largely superseded by more targeted clot-busting drugs in many settings.

Yes, Streptokinase is an approved drug. It has reached clinical phase 4. It is classified as a Enzyme.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2108147. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Streptokinase sur PillFYI

Données Clés

Liens externes

ChEMBL CHEMBL2108147

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.